2006 Meeting Home

      Call for Abstracts

      Scientific Program

      Pre-Conf. Symposium

      Photo Galleries

      Young Investigators

      Venue/Travel Info

      Stipend Awardees

      Support/Exhibition

      Past Meetings

      Society Home

Philips: From Bench to Bedside
Thursday, August 31, 2006 / 12:00 - 2:00 p.m.
Kings Ballroom
Including Lunch for Participants of the Workshop

Select the following link to register for the workshop: https://www.123signup.com/register?id=qmskj
(Please register for only ONE of the workshops on Thursday as the three are being held at the same time.)

Agent Research for Molecular Imaging at Philips
Dr. Holger Gruell, Philips Research
Abstract: The ever-growing insights into biology and disease pathways provide new opportunities for medical imaging to diagnose diseases at a molecular level. Disease specific molecules can be visualized in-vivo to allow for early diagnosis, long before clinical symptoms develop, followed by targeted treatment of the disease. In addition, molecular imaging can be used to tailor therapy to the individual patient. Medical imaging equipment, dedicated software and contrast agents homing in on disease markers are the main assets for Molecular Imaging. Within Philips Research, the first two topics have already received attention for a number of years. Recently, Philips Research also started to focus on the study of molecular imaging agents. The talk will present the latest efforts in this field as well as the approach taken by Philips Research, where intensive collaboration is sought with, generally academic, partners. Also attention will be paid to the dedicated facilities created to perform the work, within a highly multidisciplinary setting. Our ambition is to perform research, together with partners with complementary expertise, in all fields necessary to efficiently translate early research on molecular imaging into clinically relevant applications.

Optical Fluorescence Imaging of Breast Cancer
Michiel van Beek1, Leon Bakker1, Martin van der Mark1, Marjolein van der Voort1, Tim Nielsen1, Thomas Koehler1, Ronny Ziegler1, Kai Licha2, Martin Pessel2, Andrea Feuerabend3, J.P. Meeuwse4, Dirk van Pijkeren5, Sjaak Deckers5.
1Philips Research Europe, 2Schering AG, Berlin, Germany, 3Philips Design, 4Philips Applied Technologies, 5Philips Medical Systems.
Abstract: Philips and Schering AG Germany recently joined forces in the field of optical molecular imaging. As a first application we aim at improved detection of breast cancer by diffuse fluorescence imaging. For this purpose Philips recently realized a novel imaging system for fluorescence optical mammography that can be used in combination with Schering AG's Omocianine dye.
This presentation discusses the unique combination of Philips' equipment and Schering's fluorescent contrast agent. It covers the newly developed optical imaging system, the fluorescent contrast agent and the first phantom results.

Gemini 'Time-of-Flight' - Molecular Imaging
Piotr Maniawski, MS, Senior Manager, PET/CT Clinical Science, Philips Medical Systems
Abstract: Philips Medical Systems has recently introduced to the market the GEMINI TF PET/CT system. This new system features TruFlight PET technology, the first commercial implementation of the time of flight PET. Time of flight PET offers unique advantages over conventional PET in conventional clinical studies as well as in emerging molecular imaging applications. This presentation describes the basics of the technology and its benefits for molecular imaging. In particular, the use of GEMINI TF in low count rate imaging, improvements in quantitative accuracy and small lesion detectability are discussed. Examples of the list mode and dynamic imaging capabilities are presented and illustrated with phantom and patient studies. GEMINI TF PET/CT system promises to become a powerful tool for investigators in the area of cancer, cardiac and neurological research.

Pre-Clinical Imaging
Presenter TBD


Please return for specifics at a later date.